BR9801448A - Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos. - Google Patents
Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos.Info
- Publication number
- BR9801448A BR9801448A BR9801448-0A BR9801448A BR9801448A BR 9801448 A BR9801448 A BR 9801448A BR 9801448 A BR9801448 A BR 9801448A BR 9801448 A BR9801448 A BR 9801448A
- Authority
- BR
- Brazil
- Prior art keywords
- preparation
- pharmaceutical compositions
- compositions containing
- heterocyclic compounds
- compounds
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
- C07D311/64—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with oxygen atoms directly attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/06—Six-membered rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Child & Adolescent Psychology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
Abstract
Patente de Invenção<B>"COMPOSTOS HETEROCìCLICOS, PROCESSO PARA SUA PREPARAçãO E COMPOSIçõES FARMACêUTICAS CONTENDO OS MESMOS"<D>. A invenção refere-se a compostos de fórmula (I): onde: Z representa O ou CH~ 2~ n é de 0 a 4 R, X e Y são como definidos na descrição, e A representa um grupo onde R^ 1^, R^ 2^, R^ 6^, R^ 7^ e T' são como definidos na descrição. Medicamentos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9705110A FR2762598A1 (fr) | 1997-04-25 | 1997-04-25 | Nouveaux composes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennnent |
Publications (2)
Publication Number | Publication Date |
---|---|
BR9801448A true BR9801448A (pt) | 2000-02-08 |
BR9801448B1 BR9801448B1 (pt) | 2009-01-13 |
Family
ID=9506306
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI9801448-0A BR9801448B1 (pt) | 1997-04-25 | 1998-04-24 | compostos heterocÍclicos, processo para sua preparaÇço e composiÇÕes farmacÊuticas contendo os mesmos. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5919814A (pt) |
EP (1) | EP0873993B1 (pt) |
JP (1) | JP4125418B2 (pt) |
CN (1) | CN1145622C (pt) |
AT (1) | ATE213496T1 (pt) |
AU (1) | AU736716B2 (pt) |
BR (1) | BR9801448B1 (pt) |
CA (1) | CA2235421C (pt) |
DE (1) | DE69803894T2 (pt) |
DK (1) | DK0873993T3 (pt) |
ES (1) | ES2173556T3 (pt) |
FR (1) | FR2762598A1 (pt) |
HK (1) | HK1014956A1 (pt) |
HU (1) | HU223468B1 (pt) |
NO (1) | NO317742B1 (pt) |
NZ (1) | NZ330279A (pt) |
PL (1) | PL198572B1 (pt) |
PT (1) | PT873993E (pt) |
ZA (1) | ZA983490B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19548708A1 (de) * | 1995-12-23 | 1997-06-26 | Merck Patent Gmbh | Cyclische Sulfone |
FR2799757B1 (fr) * | 1999-10-15 | 2001-12-14 | Adir | Nouveaux derives polycycliques azaindoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2805993B1 (fr) * | 2000-03-08 | 2004-01-16 | Adir | Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement du developpement de la tolerance aux composes nitres |
US6750213B2 (en) | 2000-10-19 | 2004-06-15 | Merck & Co., Inc. | Estrogen receptor modulators |
WO2002032373A2 (en) * | 2000-10-19 | 2002-04-25 | Merck & Co., Inc. | Estrogen receptor modulators |
EP2166013B1 (en) * | 2001-10-04 | 2018-01-24 | Akzo Nobel N.V. | Oligomeric, hydroxy-terminated phosphonates |
DE60334202D1 (de) | 2002-04-24 | 2010-10-28 | Merck Sharp & Dohme | Modulatoren des östrogenrezeptors |
FR2918370B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2918372B1 (fr) * | 2007-07-02 | 2009-08-28 | Servier Lab | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3737195A1 (de) * | 1987-11-03 | 1989-05-18 | Bayer Ag | Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
FR2691149B1 (fr) * | 1992-05-18 | 1994-07-08 | Adir | Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. |
FR2716680B1 (fr) * | 1994-02-25 | 1996-04-05 | Adir | Nouveaux dérivés de benzodioxane, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
-
1997
- 1997-04-25 FR FR9705110A patent/FR2762598A1/fr not_active Withdrawn
-
1998
- 1998-04-20 CA CA002235421A patent/CA2235421C/fr not_active Expired - Fee Related
- 1998-04-22 NO NO19981814A patent/NO317742B1/no unknown
- 1998-04-23 ES ES98400987T patent/ES2173556T3/es not_active Expired - Lifetime
- 1998-04-23 AT AT98400987T patent/ATE213496T1/de not_active IP Right Cessation
- 1998-04-23 EP EP98400987A patent/EP0873993B1/fr not_active Expired - Lifetime
- 1998-04-23 DE DE69803894T patent/DE69803894T2/de not_active Expired - Fee Related
- 1998-04-23 DK DK98400987T patent/DK0873993T3/da active
- 1998-04-23 PT PT98400987T patent/PT873993E/pt unknown
- 1998-04-24 AU AU63591/98A patent/AU736716B2/en not_active Ceased
- 1998-04-24 JP JP11497998A patent/JP4125418B2/ja not_active Expired - Fee Related
- 1998-04-24 ZA ZA983490A patent/ZA983490B/xx unknown
- 1998-04-24 HU HU9800964A patent/HU223468B1/hu not_active IP Right Cessation
- 1998-04-24 CN CNB981073328A patent/CN1145622C/zh not_active Expired - Fee Related
- 1998-04-24 PL PL325989A patent/PL198572B1/pl unknown
- 1998-04-24 BR BRPI9801448-0A patent/BR9801448B1/pt not_active IP Right Cessation
- 1998-04-24 US US09/066,235 patent/US5919814A/en not_active Expired - Fee Related
- 1998-04-24 NZ NZ330279A patent/NZ330279A/en unknown
-
1999
- 1999-01-14 HK HK99100203A patent/HK1014956A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE213496T1 (de) | 2002-03-15 |
AU736716B2 (en) | 2001-08-02 |
ES2173556T3 (es) | 2002-10-16 |
EP0873993B1 (fr) | 2002-02-20 |
DK0873993T3 (da) | 2002-06-10 |
NO981814L (no) | 1998-10-26 |
FR2762598A1 (fr) | 1998-10-30 |
PT873993E (pt) | 2002-07-31 |
BR9801448B1 (pt) | 2009-01-13 |
HU223468B1 (hu) | 2004-07-28 |
JPH10298178A (ja) | 1998-11-10 |
JP4125418B2 (ja) | 2008-07-30 |
HUP9800964A3 (en) | 2000-06-28 |
HK1014956A1 (en) | 1999-10-08 |
DE69803894D1 (de) | 2002-03-28 |
HU9800964D0 (en) | 1998-06-29 |
PL325989A1 (en) | 1998-10-26 |
ZA983490B (en) | 1998-10-29 |
EP0873993A1 (fr) | 1998-10-28 |
US5919814A (en) | 1999-07-06 |
CN1197797A (zh) | 1998-11-04 |
NO981814D0 (no) | 1998-04-22 |
NZ330279A (en) | 1998-11-25 |
DE69803894T2 (de) | 2002-11-07 |
CN1145622C (zh) | 2004-04-14 |
CA2235421C (fr) | 2003-09-16 |
NO317742B1 (no) | 2004-12-13 |
PL198572B1 (pl) | 2008-06-30 |
CA2235421A1 (fr) | 1998-10-25 |
HUP9800964A2 (hu) | 2000-05-28 |
AU6359198A (en) | 1998-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9911771A (pt) | Compostos cìclicos substituìdos, um processo para sua preparação e composições farmacêuticas que contêm os mesmos | |
BR9913592A (pt) | Compostos, processo de preparação dos compostos, e, composições farmacêuticas | |
BR0108871A (pt) | Composto, processo de preparação de compostos, e, composição farmacêutica | |
BR9909565A (pt) | Derivados bicìclicos do ácido hidroxâmico | |
BR9806296A (pt) | Derivados de ácido sulfìnico e sua preparação e uso | |
YU56995A (sh) | Soli derivata indola | |
BR9812944A (pt) | Inibidores bicìclicos da cinase | |
BR9713465A (pt) | Inibidores metalotprotease de amina cìclica sibstituìda | |
BR9807843A (pt) | Heterociclos bicìclicos dissubstituìdos, sua preparação e seu emprego como medicamentos | |
YU13396A (sh) | N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima | |
BR9911488A (pt) | Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto | |
BR0011738A (pt) | Derivados de benzeno, processo para a preparação dos mesmos e composições farmacêuticas que os contêm | |
BR0314379A (pt) | Quinazolinonas espirocondensadas e a sua utilização como inibidores de fosfodiesterase | |
BR9916004A (pt) | Inibidores de proteinase c de pró-colágeno | |
BR9910573A (pt) | Compostos antipicornavirais, preparação e uso dos mesmos | |
BR0112521A (pt) | Indolquinazolinonas | |
BR0307461A (pt) | Derivados de quinazolinona e seu uso como agonistas de cb | |
BR9805031A (pt) | Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
BR9801448A (pt) | Compostos heterocìclicos, processo para sua preparação e composições farmacêuticas contendo os mesmos. | |
BR0003313A (pt) | Novos compostos diméricos substituìdos, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos | |
BR9813217A (pt) | Tetraciclos, processo para a produção dos mesmos e preparações farmacêuticas contendo estes compostos | |
JPS5665869A (en) | Novel 22hydroxyalkyll3*4*55trihydroxyypiperidine compound* its manufacture and drug | |
BR9809234A (pt) | Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo. | |
BR9712707A (pt) | Derivados de ácido 4-bifenil-4-hidroxibutìrico substituìdo com inibidores de metaloprotease de matriz | |
BR0012478A (pt) | Derivados de aminotiazóis, sua preparação e composição farmacêuticas contendo os mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Transfer |
Free format text: LES LABORATOIRES SERVIER (FR) |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 10/02/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
B24C | Patent annual fee: request for for restoration |
Free format text: REFERENTE A 12A E 13A ANUIDADES. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE AS 12A E 13A ANUIDADES. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |